Canadian CBD company Maricann has continued its European expansion with plans to open a retail location in Switzerland, and is looking for further opportunities. Maricann, operating as the Wayland Group, will open its doors in Zurich in 2019.
Wayland CEO Ben Ward said: “A retail footprint in Switzerland grants us the opportunity to bring an elevated standard of product to market in Europe, while also engaging these insights and learnings as we widen our potential retail expansion to Canada.”
...
Need help?
Contact a sales representative right now and don’t wait
“ Canadian CBD company adds Swiss store to its operation in Europe ”
Buy report request information:
“ Canadian CBD company adds Swiss store to its operation in Europe ”
Canadian CBD company Maricann has continued its European expansion with plans to open a retail location in Switzerland, and is looking for further opportunities. Maricann, operating as the Wayland Group, will open its doors in Zurich in 2019.
Wayland CEO Ben Ward said: “A retail footprint in Switzerland grants us the opportunity to bring an elevated standard of product to market in Europe, while also engaging these insights and learnings as we widen our potential retail expansion to Canada.”
Get access to premium content that is normally only available for subscribers. For the duration of a week, you can read our news analysis, identify market trends and understand upcoming changes in the industry, which will enable you to get ahead of your competitors.
Benefits of subscription plans:
Stay informed of any legal and market change in the sector that impacts your organization
Maximise resources by getting market and legal data analysis daily in one place
Make smart decisions by understanding how the regulatory and market landscape evolves
Anticipate risks in your decisions by monitoring regulatory changes that impact your organization
Need help?
Contact a sales representative right now and don’t wait
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.
By signing up you agree to our Terms and Conditions Please note trial access may take up to 24 hours to be granted as access must be qualified by a member of the CBD-Intel team.
